3.7. KV Showed an Antiproliferative Effect and Enhanced the Anticancer Effects of Oxaliplatin in KRAS-Mutated Patient-Derived Pancreatic Cancer Organoids. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.